Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 286

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Leptin in human physiology and therapeutics

Open access
Dardeno, Tina A., Chou, Sharon H., Moon, Hyun-Seuk, Chamberland, John P., Fiorenza, Christina G., Mantzoros, Christos S.·2010·Frontiers in Neuroendocrinology

Abstract

Leptin regulates energy homeostasis and reproductive, neuroendocrine, immune, and metabolic functions. In this review, we describe the role of leptin in human physiology and review evidence from recent “proof of concept” clinical trials using recombinant human leptin in subjects with congenital leptin deficiency, hypoleptinemia associated with energy-deficient states, and hyperleptinemia associated with garden-variety obesity. Since most obese individuals are largely leptin-tolerant or -resistant, therapeutic uses of leptin are currently limited to patients with complete or partial leptin deficiency, including hypothalamic amenorrhea and lipoatrophy. Leptin administration in these energy-deficient states may help restore associated neuroendocrine, metabolic, and immune function and bone metabolism. Leptin treatment is currently available for individuals with congenital leptin deficiency and congenital lipoatrophy. The long-term efficacy and safety of leptin treatment in hypothalamic amenorrhea and acquired lipoatrophy are currently under investigation. Whether combination therapy with leptin and potential leptin sensitizers will prove effective in the treatment of garden-variety obesity and whether leptin may have a role in weight loss maintenance is being greatly anticipated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yfrne.2010.06.002

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 194

  1. Abizaid, 2006, Thoughts for food: brain mechanisms and peripheral energy balance, Neuron, 51, 691, 10.1016/j.neuron.2006.08.025 · DOI
  2. Ahima, 1999, Regulation of neuronal and glial proteins by leptin: implications for brain development, Endocrinology, 140, 2755, 10.1210/endo.140.6.6774 · DOI · Paper page
  3. Ahima, 1996, Role of leptin in the neuroendocrine response to fasting, Nature, 382, 250, 10.1038/382250a0 · DOI · Paper page
  4. Arora, 2006, Role of neuropeptides in appetite regulation and obesity – a review, Neuropeptides, 40, 375, 10.1016/j.npep.2006.07.001 · DOI · Paper page
  5. Audi, 1998, Leptin in relation to resumption of menses in women with anorexia nervosa, Mol. Psychiat., 3, 544, 10.1038/sj.mp.4000418 · DOI
  6. Baldock, 2006, Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways, J. Bone Miner. Res., 21, 1600, 10.1359/jbmr.060705 · DOI
  7. Balthasar, 2004, Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis, Neuron, 42, 983, 10.1016/j.neuron.2004.06.004 · DOI · Paper page
  8. Balthasar, 2005, Divergence of melanocortin pathways in the control of food intake and energy expenditure, Cell, 123, 493, 10.1016/j.cell.2005.08.035 · DOI · Paper page
  9. Banks, 2001, Leptin transport across the blood–brain barrier: implications for the cause and treatment of obesity, Curr. Pharm. Des., 7, 125, 10.2174/1381612013398310 · DOI
  10. Banks, 2000, Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice, Am. J. Physiol. Endocrinol. Metab., 278, E1158, 10.1152/ajpendo.2000.278.6.E1158 · DOI
  11. Banks, 2002, Leptin transport across the blood–brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene, Brain Res., 950, 130, 10.1016/S0006-8993(02)03013-5 · DOI
  12. Bayer, 1999, Survival of rat MCH (melanin-concentrating hormone) neurons in hypothalamus slice culture: histological, pharmacological and molecular studies, Cell Tissue Res., 297, 23, 10.1007/s004410051330 · DOI
  13. Berti, 1997, Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect, Diabetologia, 40, 606, 10.1007/s001250050722 · DOI
  14. Bjorbaek, 1998, Expression of leptin receptor isoforms in rat brain microvessels, Endocrinology, 139, 3485, 10.1210/endo.139.8.6154 · DOI · Paper page
  15. Boden, 1996, Effect of fasting on serum leptin in normal human subjects, J. Clin. Endocrinol. Metab., 81, 3419
  16. Boden, 2008, Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals, Diabetes, 57, 2438, 10.2337/db08-0604 · DOI · Paper page
  17. Bouret, 2004, Trophic action of leptin on hypothalamic neurons that regulate feeding, Science, 304, 108, 10.1126/science.1095004 · DOI · Paper page
  18. Brennan, 2009, R-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans, Eur. J. Endocrinol., 160, 173, 10.1530/EJE-08-0597 · DOI
  19. Burguera, 2000, Obesity is associated with a decreased leptin transport across the blood–brain barrier in rats, Diabetes, 49, 1219, 10.2337/diabetes.49.7.1219 · DOI
  20. Caldefie-Chezet, 2003, Leptin regulates functional capacities of polymorphonuclear neutrophils, Free Radic. Res., 37, 809, 10.1080/1071576031000097526 · DOI
  21. Capeau, 2005, Diseases of adipose tissue: genetic and acquired lipodystrophies, Biochem. Soc. Trans., 33, 1073, 10.1042/BST0331073 · DOI
  22. Carpenter, 1998, Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor, Proc. Natl. Acad. Sci. USA, 95, 6061, 10.1073/pnas.95.11.6061 · DOI
  23. Chan, 2006, Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans, Proc. Natl. Acad. Sci. USA, 103, 8481, 10.1073/pnas.0505429103 · DOI · Paper page
  24. Chan, 2007, Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans, Clin. Endocrinol. (Oxf.), 66, 49, 10.1111/j.1365-2265.2006.02684.x · DOI · Paper page
  25. Chan, 2009, It takes two to tango: combined amylin/leptin agonism as a potential approach to obesity drug development, J. Invest. Med., 57, 777, 10.2310/JIM.0b013e3181b91911 · DOI
  26. Chehab, 1996, Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin, Nat. Genet., 12, 318, 10.1038/ng0396-318 · DOI · Paper page
  27. Cirmanova, 2008, The effect of leptin on bone: an evolving concept of action, Physiol. Res., 57, S143, 10.33549/physiolres.931499 · DOI
  28. Collins, 1996, Role of leptin in fat regulation, Nature, 380, 677, 10.1038/380677a0 · DOI · Paper page
  29. Considine, 1996, Serum immunoreactive-leptin concentrations in normal-weight and obese humans, New Engl. J. Med., 334, 292, 10.1056/NEJM199602013340503 · DOI · Paper page
  30. Costa, 1997, Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants, Neuroreport, 8, 1131, 10.1097/00001756-199703240-00014 · DOI
  31. Cota, 2008, The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity, J. Neurosci., 28, 7202, 10.1523/JNEUROSCI.1389-08.2008 · DOI
  32. Cota, 2006, Hypothalamic mTOR signaling regulates food intake, Science, 312, 927, 10.1126/science.1124147 · DOI · Paper page
  33. Cowley, 2003, Hypothalamic melanocortin neurons integrate signals of energy state, Eur. J. Pharmacol., 480, 3, 10.1016/j.ejphar.2003.08.087 · DOI
  34. Cowley, 2001, Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus, Nature, 411, 480, 10.1038/35078085 · DOI · Paper page
  35. Cypess, 2009, Identification and importance of brown adipose tissue in adult humans, New Engl. J. Med., 360, 1509, 10.1056/NEJMoa0810780 · DOI · Paper page
  36. Dhillon, 2006, Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis, Neuron, 49, 191, 10.1016/j.neuron.2005.12.021 · DOI · Paper page
  37. Duan, 2007, Effects of subcutaneous leptin injections on hypothalamic gene profiles in lean and ob/ob mice, Obesity (Silver Spring), 15, 2624, 10.1038/oby.2007.314 · DOI
  38. Ebihara, 2004, Long-term leptin-replacement therapy for lipoatrophic diabetes, New Engl. J. Med., 351, 615, 10.1056/NEJM200408053510623 · DOI · Paper page
  39. Elmquist, 1998, Distributions of leptin receptor mRNA isoforms in the rat brain, J. Comp. Neurol., 395, 535, 10.1002/(SICI)1096-9861(19980615)395:4<535::AID-CNE9>3.0.CO;2-2 · DOI
  40. Ernst, 2009, Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity, J. Neurosci., 29, 11582, 10.1523/JNEUROSCI.5712-08.2009 · DOI · Paper page
  41. Farooqi, 2008, Monogenic human obesity, Front. Horm. Res., 36, 1, 10.1159/000115333 · DOI
  42. Farooqi, 2007, Leptin regulates striatal regions and human eating behavior, Science, 317, 1355, 10.1126/science.1144599 · DOI · Paper page
  43. Farooqi, 2003, Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene, New Engl. J. Med., 348, 1085, 10.1056/NEJMoa022050 · DOI · Paper page
  44. Farooqi, 2002, Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency, J. Clin. Invest., 110, 1093, 10.1172/JCI0215693 · DOI · Paper page
  45. Farooqi, 2004, Monogenic human obesity syndromes, Recent Prog. Horm. Res., 59, 409, 10.1210/rp.59.1.409 · DOI
  46. Farooqi, 2005, Monogenic obesity in humans, Annu. Rev. Med., 56, 443, 10.1146/annurev.med.56.062904.144924 · DOI · Paper page
  47. Farooqi, 2007, Insights from the genetics of severe childhood obesity, Horm. Res., 68, 5, 10.1159/000110462 · DOI
  48. Fei, 1997, Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues, Proc. Natl. Acad. Sci. USA, 94, 7001, 10.1073/pnas.94.13.7001 · DOI · Paper page
  49. Finn, 1998, The stimulatory effect of leptin on the neuroendocrine reproductive axis of the monkey, Endocrinology, 139, 4652, 10.1210/endo.139.11.6297 · DOI · Paper page
  50. Fogteloo, 2003, Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans, Diabetes Nutr. Metab., 16, 109
  51. Gao, 2009, Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells, Cancer Sci., 100, 389, 10.1111/j.1349-7006.2008.01053.x · DOI
  52. Gao, 2008, Cross-talk between estrogen and leptin signaling in the hypothalamus, Am. J. Physiol. Endocrinol. Metab., 294, E817, 10.1152/ajpendo.00733.2007 · DOI
  53. Gao, 2008, Neuronal control of energy homeostasis, FEBS Lett., 582, 132, 10.1016/j.febslet.2007.11.063 · DOI
  54. Gao, 2004, Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation, Proc. Natl. Acad. Sci. USA, 101, 4661, 10.1073/pnas.0303992101 · DOI · Paper page
  55. Garris, 2007, Influences of diabetes (db/db), obese (ob/ob) and dystrophic (dy/dy) genotype mutations on hind limb bone maturation: a morphometric, radiological and cytochemical indices analysis, Diabetes Obes. Metab., 9, 311, 10.1111/j.1463-1326.2006.00603.x · DOI
  56. Gat-Yablonski, 2008, Leptin and regulation of linear growth, Curr. Opin. Clin. Nutr. Metab. Care, 11, 303, 10.1097/MCO.0b013e3282f795cf · DOI
  57. Gavrila, 2005, Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2×2 factorial, randomized, double-blinded, placebo-controlled trial, Clin. Infect. Dis., 40, 745, 10.1086/427697 · DOI
  58. Gavrilova, 2000, Leptin and diabetes in lipoatrophic mice, Nature, 403, 850, 10.1038/35002663 · DOI · Paper page
  59. Gong, 2008, Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein/neuropeptide Y neurons for normal energy homeostasis, Endocrinology, 149, 3346, 10.1210/en.2007-0945 · DOI
  60. Gordeladze, 2002, Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling, J. Cell. Biochem., 85, 825, 10.1002/jcb.10156 · DOI · Paper page
  61. Gottsch, 2004, A role for kisspeptins in the regulation of gonadotropin secretion in the mouse, Endocrinology, 145, 4073, 10.1210/en.2004-0431 · DOI · Paper page
  62. Grinspoon, 2005, Cardiovascular risk and body-fat abnormalities in HIV-infected adults, New Engl. J. Med., 352, 48, 10.1056/NEJMra041811 · DOI · Paper page
  63. Hakansson, 1998, Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus, J. Neurosci., 18, 559, 10.1523/JNEUROSCI.18-01-00559.1998 · DOI · Paper page
  64. Halaas, 1995, Weight-reducing effects of the plasma protein encoded by the obese gene, Science, 269, 543, 10.1126/science.7624777 · DOI · Paper page
  65. Hamrick, 2007, Leptin and bone: a consensus emerging?, BoneKEy-Osteovision, 4, 99, 10.1138/20070254 · DOI
  66. Hamrick, 2007, Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow, Cell Tissue Res., 327, 133, 10.1007/s00441-006-0312-3 · DOI
  67. Harris, 1998, A leptin dose-response study in obese (ob/ob) and lean (+/?) mice, Endocrinology, 139, 8, 10.1210/endo.139.1.5675 · DOI · Paper page
  68. Harvey, 2000, Essential role of phosphoinositide 3-kinase in leptin-induced K(ATP) channel activation in the rat CRI-G1 insulinoma cell line, J. Biol. Chem., 275, 4660, 10.1074/jbc.275.7.4660 · DOI
  69. Heiman, 1997, Leptin inhibition of the hypothalamic-pituitary–adrenal axis in response to stress, Endocrinology, 138, 3859, 10.1210/endo.138.9.5366 · DOI · Paper page
  70. Heymsfield, 1999, Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial, JAMA, 282, 1568, 10.1001/jama.282.16.1568 · DOI · Paper page
  71. Hileman, 2002, Characterization of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity, Endocrinology, 143, 775, 10.1210/endo.143.3.8669 · DOI · Paper page
  72. Hill, 2008, Hypothalamic pathways linking energy balance and reproduction, Am. J. Physiol. Endocrinol. Metab., 294, E827, 10.1152/ajpendo.00670.2007 · DOI · Paper page
  73. Holloway, 2002, Leptin inhibits osteoclast generation, J. Bone Miner. Res., 17, 200, 10.1359/jbmr.2002.17.2.200 · DOI · Paper page
  74. Hommel, 2006, Leptin receptor signaling in midbrain dopamine neurons regulates feeding, Neuron, 51, 801, 10.1016/j.neuron.2006.08.023 · DOI · Paper page
  75. Hosoi, 2002, Brain stem is a direct target for leptin’s action in the central nervous system, Endocrinology, 143, 3498, 10.1210/en.2002-220077 · DOI
  76. Howard, 2004, Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3, Nat. Med., 10, 734, 10.1038/nm1072 · DOI · Paper page
  77. Howard, 1999, Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice, J. Clin. Invest., 104, 1051, 10.1172/JCI6762 · DOI · Paper page
  78. Hsu, 2007, Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia, Clin. Exp. Immunol., 150, 332, 10.1111/j.1365-2249.2007.03491.x · DOI
  79. Hukshorn, 2000, Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men, J. Clin. Endocrinol. Metab., 85, 4003, 10.1210/jcem.85.11.6955 · DOI · Paper page
  80. Irwig, 2004, Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat, Neuroendocrinology, 80, 264, 10.1159/000083140 · DOI · Paper page
  81. Jacobson, 2005, Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women, Clin. Infect. Dis., 40, 1837, 10.1086/430379 · DOI
  82. Jimerson, 2000, Decreased serum leptin in bulimia nervosa, J. Clin. Endocrinol. Metab., 85, 4511
  83. Jurimae, 2008, The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women, J. Bone Miner. Metab., 26, 618, 10.1007/s00774-008-0861-5 · DOI
  84. Kiess, 2008, Adipocytes and adipose tissue, Best Pract. Res. Clin. Endocrinol. Metab., 22, 135, 10.1016/j.beem.2007.10.002 · DOI · Paper page
  85. Kim, 2006, Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis, Nat. Neurosci., 9, 901, 10.1038/nn1731 · DOI · Paper page
  86. Kim, 2000, In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin, Endocrinology, 141, 2328, 10.1210/endo.141.7.7536 · DOI
  87. Krude, 1998, Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans, Nat. Genet., 19, 155, 10.1038/509 · DOI · Paper page
  88. Lee, 2006, Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy, J. Clin. Endocrinol. Metab., 91, 2605, 10.1210/jc.2005-1545 · DOI · Paper page
  89. Legradi, 1997, Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus, Endocrinology, 138, 2569, 10.1210/endo.138.6.5209 · DOI · Paper page
  90. Leinninger, 2008, LRb signals act within a distributed network of leptin-responsive neurones to mediate leptin action, Acta Physiol. (Oxf.), 192, 49, 10.1111/j.1748-1716.2007.01784.x · DOI · Paper page
  91. Lejeune, 2003, Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men, Int. J. Obes. Relat. Metab. Disord., 27, 1494, 10.1038/sj.ijo.0802431 · DOI
  92. Leshan, 2006, Leptin receptor signaling and action in the central nervous system, Obesity (Silver Spring), 14, 208S, 10.1038/oby.2006.310 · DOI
  93. Levin, 2004, Obesity-prone rats have normal blood–brain barrier transport but defective central leptin signaling before obesity onset, Am. J. Physiol. Regul. Integr. Comp. Physiol., 286, R143, 10.1152/ajpregu.00393.2003 · DOI · Paper page
  94. Licinio, 2004, Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults, Proc. Natl. Acad. Sci. USA, 101, 4531, 10.1073/pnas.0308767101 · DOI · Paper page
  95. Lim, 2009, AMPK as a mediator of hormonal signalling, J. Mol. Endocrinol., 44, 87, 10.1677/JME-09-0063 · DOI · Paper page
  96. Loffreda, 1998, Leptin regulates proinflammatory immune responses, FASEB J., 12, 57, 10.1096/fasebj.12.1.57 · DOI · Paper page
  97. Logothetis, 2002, The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal, Philos. Trans. Royal Soc. Lond. B Biol. Sci., 357, 1003, 10.1098/rstb.2002.1114 · DOI · Paper page
  98. Lord, 1998, Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression, Nature, 394, 897, 10.1038/29795 · DOI · Paper page
  99. Lorentzon, 1986, Osteopenia in mice with genetic diabetes, Diabetes Res. Clin. Pract., 2, 157, 10.1016/S0168-8227(86)80017-1 · DOI
  100. Mancuso, 2002, Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia, J. Immunol., 168, 4018, 10.4049/jimmunol.168.8.4018 · DOI · Paper page
  101. Mantzoros, 1997, Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain, J. Clin. Endocrinol. Metab., 82, 1845
  102. Mantzoros, 1999, The role of leptin in human obesity and disease: a review of current evidence, Ann. Intern. Med., 130, 671, 10.7326/0003-4819-130-8-199904200-00014 · DOI · Paper page
  103. Mantzoros, 2009, Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?, J. Clin. Endocrinol. Metab., 94, 1089, 10.1210/jc.2009-0340 · DOI
  104. Mantzoros, 2010, W(h)ither metreleptin for lipodystrophy and the metabolic syndrome?, Endocr. Pract., 1, 18
  105. Mantzoros, 2001, Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans, J. Clin. Endocrinol. Metab., 86, 3284, 10.1210/jcem.86.7.7644 · DOI · Paper page
  106. Mantzoros, 1996, Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice, Diabetes, 45, 909, 10.2337/diab.45.7.909 · DOI · Paper page
  107. Margetic, 2002, Leptin: a review of its peripheral actions and interactions, Int. J. Obes. Relat. Metab. Disord., 26, 1407, 10.1038/sj.ijo.0802142 · DOI · Paper page
  108. Maroni, 2003, Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle, Mol. Cell. Endocrinol., 201, 109, 10.1016/S0303-7207(02)00427-6 · DOI
  109. Matarese, 2005, Leptin in immunology, J. Immunol., 174, 3137, 10.4049/jimmunol.174.6.3137 · DOI · Paper page
  110. Matochik, 2005, Effect of leptin replacement on brain structure in genetically leptin-deficient adults, J. Clin. Endocrinol. Metab., 90, 2851, 10.1210/jc.2004-1979 · DOI
  111. Mayer, 1951, Hereditary diabetes in genetically obese mice, Science, 113, 746, 10.1126/science.113.2948.746 · DOI
  112. McMurtry, 2009, Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells, Clin. Exp. Metast., 26, 197, 10.1007/s10585-008-9231-x · DOI
  113. Miller, 1998, Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake, J. Clin. Endocrinol. Metab., 83, 2309
  114. Minokoshi, 2004, AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus, Nature, 428, 569, 10.1038/nature02440 · DOI · Paper page
  115. Moitra, 1998, Life without white fat: a transgenic mouse, Genes Dev., 12, 3168, 10.1101/gad.12.20.3168 · DOI · Paper page
  116. Montague, 1997, Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution, Diabetes, 46, 342, 10.2337/diab.46.3.342 · DOI · Paper page
  117. Morris, 2009, Recent advances in understanding leptin signaling and leptin resistance, Am. J. Physiol. Endocrinol. Metab., 297, E1247, 10.1152/ajpendo.00274.2009 · DOI · Paper page
  118. Morrison, 2009, Leptin signaling in brain: a link between nutrition and cognition?, Biochim. Biophys. Acta, 1792, 401, 10.1016/j.bbadis.2008.12.004 · DOI
  119. Morton, 2005, Leptin action in the forebrain regulates the hindbrain response to satiety signals, J. Clin. Invest., 115, 703, 10.1172/JCI200522081 · DOI · Paper page
  120. Munzberg, 2007, Appropriate inhibition of orexigenic hypothalamic arcuate nucleus neurons independently of leptin receptor/STAT3 signaling, J. Neurosci., 27, 69, 10.1523/JNEUROSCI.3168-06.2007 · DOI
  121. Myers, 2004, Leptin receptor signaling and the regulation of mammalian physiology, Recent Prog. Horm. Res., 59, 287, 10.1210/rp.59.1.287 · DOI · Paper page
  122. Nagy, 2003, Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin, Clin. Infect. Dis., 36, 795, 10.1086/367859 · DOI
  123. Nishiyama, 2009, Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations, Pediatr. Int., 51, 775, 10.1111/j.1442-200X.2009.02863.x · DOI
  124. Niswender, 2003, Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia, Diabetes, 52, 227, 10.2337/diabetes.52.2.227 · DOI · Paper page
  125. Niswender, 2001, Intracellular signalling. Key enzyme in leptin-induced anorexia, Nature, 413, 794, 10.1038/35101657 · DOI · Paper page
  126. Ogunwobi, 2007, The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt, Int. J. Colorectal Dis., 22, 401, 10.1007/s00384-006-0181-y · DOI
  127. Ollmann, 1997, Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein, Science, 278, 135, 10.1126/science.278.5335.135 · DOI · Paper page
  128. Oral, 2002, Effect of leptin replacement on pituitary hormone regulation in patients with severe lipodystrophy, J. Clin. Endocrinol. Metab., 87, 3110, 10.1210/jcem.87.7.8591 · DOI · Paper page
  129. Oswal, 2009, Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity, Obesity (Silver Spring), 18, 221, 10.1038/oby.2009.228 · DOI
  130. Ozcan, 2009, Endoplasmic reticulum stress plays a central role in development of leptin resistance, Cell Metab., 9, 35, 10.1016/j.cmet.2008.12.004 · DOI · Paper page
  131. Ozcan, 2004, Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes, Science, 306, 457, 10.1126/science.1103160 · DOI · Paper page
  132. Papathanassoglou, 2006, Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice, J. Immunol., 176, 7745, 10.4049/jimmunol.176.12.7745 · DOI · Paper page
  133. Pardini, 1998, Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes, J. Clin. Endocrinol. Metab., 83, 503
  134. Paz-Filho, 2009, Congenital leptin deficiency and thyroid function, Thyroid Res., 2, 11, 10.1186/1756-6614-2-11 · DOI
  135. Paz, 2008, Leptin replacement improves cognitive development, PLoS One, 3, 7
  136. Pierroz, 2002, Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity, Diabetes, 51, 1337, 10.2337/diabetes.51.5.1337 · DOI
  137. Plum, 2006, Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity, J Clin Invest, 116, 1886, 10.1172/JCI27123 · DOI · Paper page
  138. Pombo, 2001, Hormonal control of growth hormone secretion, Horm. Res., 55, 11, 10.1159/000063456 · DOI
  139. Qu, 1996, A role for melanin-concentrating hormone in the central regulation of feeding behaviour, Nature, 380, 243, 10.1038/380243a0 · DOI · Paper page
  140. Quennell, 2009, Leptin indirectly regulates gonadotropin-releasing hormone neuronal function, Endocrinology, 150, 2805, 10.1210/en.2008-1693 · DOI · Paper page
  141. Rahmouni, 2003, Intracellular mechanisms involved in leptin regulation of sympathetic outflow, Hypertension, 41, 763, 10.1161/01.HYP.0000048342.54392.40 · DOI · Paper page
  142. Rahmouni, 2009, Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin, Diabetes, 58, 536, 10.2337/db08-0822 · DOI
  143. Ravussin, 2009, Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy, Obesity (Silver Spring), 17, 1736, 10.1038/oby.2009.184 · DOI · Paper page
  144. Rios, 2001, Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity, Mol. Endocrinol., 15, 1748, 10.1210/mend.15.10.0706 · DOI · Paper page
  145. Roemmich, 2003, Relationship of leptin to bone mineralization in children and adolescents, J. Clin. Endocrinol. Metab., 88, 599, 10.1210/jc.2001-012025 · DOI
  146. Rogge, 2008, CART peptides: regulators of body weight, reward and other functions, Nat. Rev. Neurosci., 9, 747, 10.1038/nrn2493 · DOI · Paper page
  147. Rosenbaum, 1996, Effects of gender, body composition, and menopause on plasma concentrations of leptin, J. Clin. Endocrinol. Metab., 81, 3424
  148. Rosenbaum, 2008, Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli, J. Clin. Invest., 118, 2583
  149. Roth, 2008, Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies, Proc. Natl. Acad. Sci. USA, 105, 7257, 10.1073/pnas.0706473105 · DOI · Paper page
  150. Saad, 1997, Sexual dimorphism in plasma leptin concentration, J. Clin. Endocrinol. Metab., 82, 579
  151. Sahu, 1998, Leptin decreases food intake induced by melanin-concentrating hormone (MCH), galanin (GAL) and neuropeptide Y (NPY) in the rat, Endocrinology, 139, 4739, 10.1210/endo.139.11.6432 · DOI
  152. Sanchez, 2004, Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone, J. Clin. Invest., 114, 357, 10.1172/JCI21620 · DOI
  153. Sato, 2007, Central control of bone remodeling by neuromedin U, Nat. Med., 13, 1234, 10.1038/nm1640 · DOI
  154. Scarpace, 1997, Leptin increases uncoupling protein expression and energy expenditure, Am. J. Physiol., 273, E226
  155. Segal-Lieberman, 2003, Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype, Proc. Natl. Acad. Sci. USA, 100, 10085, 10.1073/pnas.1633636100 · DOI
  156. Shahab, 2005, Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates, Proc. Natl. Acad. Sci. USA, 102, 2129, 10.1073/pnas.0409822102 · DOI · Paper page
  157. Sharma, 2008, Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects, J. Clin. Endocrinol. Metab., 93, 4532, 10.1210/jc.2008-1001 · DOI · Paper page
  158. Sharma, 2009, Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism, Eur. J. Pharmacol., 617, 113, 10.1016/j.ejphar.2009.06.037 · DOI
  159. Shimada, 1998, Mice lacking melanin-concentrating hormone are hypophagic and lean, Nature, 396, 670, 10.1038/25341 · DOI · Paper page
  160. Sinha, 1996, Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects, J. Clin. Invest., 97, 1344, 10.1172/JCI118551 · DOI · Paper page
  161. Smith, 2006, KiSS-1 neurones are direct targets for leptin in the ob/ob mouse, J. Neuroendocrinol., 18, 298, 10.1111/j.1365-2826.2006.01417.x · DOI · Paper page
  162. Smith, 2008, Neurophysiology of hunger and satiety, Dev. Disabil. Res. Rev., 14, 96, 10.1002/ddrr.13 · DOI
  163. Stanley, 1984, Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus, Life Sci., 35, 2635, 10.1016/0024-3205(84)90032-8 · DOI · Paper page
  164. Ste Marie, 2000, A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors, Proc. Natl. Acad. Sci. USA, 97, 12339, 10.1073/pnas.220409497 · DOI · Paper page
  165. Steinberg, 2006, The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans, J. Clin. Endocrinol. Metab., 91, 3592, 10.1210/jc.2006-0638 · DOI
  166. Steinberg, 2003, AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment, Am. J. Physiol. Endocrinol. Metab., 284, E648, 10.1152/ajpendo.00318.2002 · DOI
  167. Steppan, 2000, Leptin is a potent stimulator of bone growth in ob/ob mice, Regul. Pept., 92, 73, 10.1016/S0167-0115(00)00152-X · DOI · Paper page
  168. Steppan, 1999, A role for leptin in brain development, Biochem. Biophys. Res. Commun., 256, 600, 10.1006/bbrc.1999.0382 · DOI
  169. Sternson, 2005, Topographic mapping of VMH→arcuate nucleus microcircuits and their reorganization by fasting, Nat. Neurosci., 8, 1356, 10.1038/nn1550 · DOI · Paper page
  170. Tartaglia, 1997, The leptin receptor, J. Biol. Chem., 272, 6093, 10.1074/jbc.272.10.6093 · DOI · Paper page
  171. Thomas, 1999, Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes, Endocrinology, 140, 1630, 10.1210/endo.140.4.6637 · DOI · Paper page
  172. Thompson, 2004, Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary–gonadal axis, J. Neuroendocrinol., 16, 850, 10.1111/j.1365-2826.2004.01240.x · DOI · Paper page
  173. Tritos, 1997, Leptin: its role in obesity and beyond, Diabetologia, 40, 1371, 10.1007/s001250050838 · DOI
  174. Tu, 2008, Soluble receptor inhibits leptin transport, J. Cell. Physiol., 214, 301, 10.1002/jcp.21195 · DOI
  175. Tung, 2008, Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus, J. Neurosci., 28, 12419, 10.1523/JNEUROSCI.3412-08.2008 · DOI
  176. Turek, 2010, Mechanisms of amylin/leptin synergy in rodent models, Endocrinology, 151, 143, 10.1210/en.2009-0546 · DOI
  177. Udagawa, 2006, The role of leptin in the development of the cortical neuron in mouse embryos, Brain Res., 1120, 74, 10.1016/j.brainres.2006.08.116 · DOI
  178. Uehara, 1998, Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin, Diabetes, 47, 890, 10.2337/diabetes.47.6.890 · DOI
  179. Valassi, 2008, Neuroendocrine control of food intake, Nutr. Metab. Cardiovasc. Dis., 18, 158, 10.1016/j.numecd.2007.06.004 · DOI · Paper page
  180. van der Kroon, 1982, Congenital hypothyroidism in latent obese (ob/ob) mice, Int. J. Obes., 6, 83
  181. Vila, 1998, Plasma leptin turnover rates in lean and obese Zucker rats, Endocrinology, 139, 4466
  182. Wang, 2008, Leptin regulated calcium channels of neuropeptide Y and proopiomelanocortin neurons by activation of different signal pathways, Neuroscience, 156, 89, 10.1016/j.neuroscience.2008.04.079 · DOI
  183. Wang, 2009, Identification and characterization of a leptin-responsive neuroblastoma cell line, Biochem. Biophys. Res. Commun., 379, 835, 10.1016/j.bbrc.2008.12.157 · DOI
  184. Wang, 1997, Leptin receptor action in hepatic cells, J. Biol. Chem., 272, 16216, 10.1074/jbc.272.26.16216 · DOI
  185. Warren, 1996, Clinical review 77: evaluation of secondary amenorrhea, J. Clin. Endocrinol. Metab., 81, 437
  186. White, 1996, Leptin and OB-R: body weight regulation by a cytokine receptor, Cytokine Growth Factor Rev., 7, 303, 10.1016/S1359-6101(96)00040-8 · DOI
  187. Williams, 2006, Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation, Diabetes, 55, 3387, 10.2337/db06-0558 · DOI
  188. Wren, 2002, Hypothalamic actions of neuromedin U, Endocrinology, 143, 4227, 10.1210/en.2002-220308 · DOI
  189. Xu, 2007, Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding, Endocrinology, 148, 72, 10.1210/en.2006-1119 · DOI
  190. Yamanaka, 2003, Hypothalamic orexin neurons regulate arousal according to energy balance in mice, Neuron, 38, 701, 10.1016/S0896-6273(03)00331-3 · DOI · Paper page
  191. Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat. Med., 7, 941, 10.1038/90984 · DOI · Paper page
  192. Yu, 1997, Role of leptin in hypothalamic-pituitary function, Proc. Natl. Acad. Sci. USA, 94, 1023, 10.1073/pnas.94.3.1023 · DOI · Paper page
  193. Yue, 2000, Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy, J. Biol. Chem., 275, 37895, 10.1074/jbc.M007037200 · DOI
  194. Zhang, 1997, Crystal structure of the obese protein leptin-E100, Nature, 387, 206, 10.1038/387206a0 · DOI · Paper page

Cited by

Metadata

Authors
Dardeno, T. A., Chou, S. H., Moon, H.-S., Chamberland, J. P., Fiorenza, C. G., & Mantzoros, C. S.
Venue
Frontiers in Neuroendocrinology
Publisher
Elsevier BV
Published
2010-07
Volume
31
Issue
3
Pages
377-393
ISSN
0091-3022 (ISSN-L)
OpenAlex
W2015130768
Cited by
286
References
60
FWCI
10.49
Type
journal article
Language
en
Open access
bronze
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.